SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 16th, 2024 • Soligenix, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of [·], 2024, between Soligenix, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
FOR VALUE RECEIVED, ENDOREX CORP., a Delaware corporation (the "Company"), hereby certifies that ARIES DOMESTIC FUND, L.P., or its permitted assigns, is entitled to purchase from the Company, at any time or from time to time commencing on May 19,...Warrant Agreement • May 12th, 2000 • Endorex Corp • Pharmaceutical preparations • New York
AGREEMENT AND PLAN OF MERGER AND REORGANIZATIONMerger Agreement • August 14th, 2001 • Endorex Corp • Pharmaceutical preparations • Delaware
EXHIBIT 10.21 SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT dated as of October 21, 1998 between ENDOREX CORP., a Delaware corporation (the "Company"), and ELAN INTERNATIONAL SERVICES, LTD., a Bermuda corporation ("EIS"). R E C I T A L S:Securities Purchase Agreement • November 13th, 1998 • Endorex Corp • Pharmaceutical preparations • New York
RECITALSLicense Agreement • March 31st, 2003 • Dor Biopharma Inc • Pharmaceutical preparations
ANDTermination Agreement • March 31st, 2003 • Dor Biopharma Inc • Pharmaceutical preparations • New York
UNDERWRITING AGREEMENT between SOLIGENIX, INC. AndUnderwriting Agreement • June 18th, 2018 • Soligenix, Inc. • Pharmaceutical preparations • New York
The undersigned, Soligenix, Inc., a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Soligenix, Inc. (the “Company”)), hereby confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
BY AND BETWEEN ENDOREX CORPORATION AND COLIN BIEREmployment Agreement • October 2nd, 2001 • Endorex Corp • Pharmaceutical preparations • Illinois
Exhibit 10.31 CONSULTING AGREEMENT THIS AGREEMENT (this "Agreement") is entered into as of ______, 2001 by and between Endorex Corporation, a Delaware Corporation located at 28101 Ballard Drive, Suite F, Lake Forest, IL 60045, (the "Company"),...Consulting Agreement • October 2nd, 2001 • Endorex Corp • Pharmaceutical preparations • Illinois
EXHIBIT B REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of March 3, 2004, by and among DOR BioPharma, Inc., a Delaware corporation (the "Company"), and the Investors signatory hereto...Registration Rights Agreement • March 4th, 2004 • Dor Biopharma Inc • Pharmaceutical preparations
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2000 • Endorex Corp • Pharmaceutical preparations • Illinois
EXHIBIT 99.2 ESCROW AGREEMENT This ESCROW AGREEMENT (this "Escrow Agreement") is made and entered into as of June 30, 2003 by PARAMOUNT CAPITAL, INC., a New York corporation with an office at 787 Seventh Avenue, New York, NY 10019 (the "Placement...Escrow Agreement • July 21st, 2003 • Dor Biopharma Inc • Pharmaceutical preparations • New York
EXHIBIT 10.22 ENDOREX CORP. REGISTRATION RIGHTS AGREEMENT ----------------------------- THIS REGISTRATION RIGHTS AGREEMENT is made as of October 21, 1998 by and among ENDOREX CORP., a Delaware corporation (the "Company"), and ELAN INTERNATIONAL...Registration Rights Agreement • November 13th, 1998 • Endorex Corp • Pharmaceutical preparations • New York
EX. 10.17 SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT dated as of January 21, 1998 between ENDOREX CORP., a Delaware corporation (the "Company"), and ELAN INTERNATIONAL SERVICES, LTD., a Bermuda corporation ("EIS"). R E C I T A L S: A....Securities Purchase Agreement • July 30th, 1998 • Endorex Corp • Pharmaceutical preparations • New York
Exhibit 4.4 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT WITH RESPECT TO THE SECURITIES UNDER...Warrant Agreement • May 12th, 2000 • Endorex Corp • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this "AGREEMENT") is dated as of March 3, 2004, among DOR BioPharma, Inc., a Delaware corporation (the "COMPANY"), and the investors identified on the signature pages hereto (each, an...Securities Purchase Agreement • March 4th, 2004 • Dor Biopharma Inc • Pharmaceutical preparations • New York
WARRANT TO PURCHASE SHARES OF COMMON STOCK SOLIGENIX, INC.Warrant Agreement • April 22nd, 2024 • Soligenix, Inc. • Pharmaceutical preparations
THIS WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 22, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Soligenix, Inc., a Delaware corporation (the “Company”), up to ______ shares of Common Stock, par value $0.001 per share (the “Common Stock”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
ENDOREX CORP.Warrant Agreement • March 27th, 1998 • Endorex Corp • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 24th, 2016 • Soligenix, Inc. • Pharmaceutical preparations • Illinois
REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of March 22, 2016, by and between SOLIGENIX, INC., a Delaware corporation (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").
COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • May 8th, 2013 • Soligenix, Inc. • Pharmaceutical preparations
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the [ ] year anniversary of the Initial Exercise Date (as such date may be changed pursuant to Section 3 hereof, the “Termination Date”) but not thereafter, to subscribe for and purchase from Soligenix, Inc., a Delaware corporation (the “Company”), up to ___________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
LEASE AGREEMENTLease Agreement • March 27th, 1998 • Endorex Corp • Pharmaceutical preparations • Illinois
1 EXHIBIT 10.18 ENDOREX CORP. REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT is made as of January 21, 1998, by and among ENDOREX CORP., a Delaware corporation (the "Company"), and ELAN INTERNATIONAL SERVICES, LTD., a Bermuda...Registration Rights Agreement • March 27th, 1998 • Endorex Corp • Pharmaceutical preparations • New York
LICENSE AGREEMENTLicense Agreement • November 13th, 1998 • Endorex Corp • Pharmaceutical preparations • New York
DOR BIOPHARMA, INC. and American Stock Transfer & Trust Company, as Rights Agent RIGHTS AGREEMENT Dated as of June 22, 2007Rights Agreement • June 22nd, 2007 • Dor Biopharma Inc • Pharmaceutical preparations • Delaware
Rights Agreement, dated as of June 22, 2007 (“Agreement”), between Dor BioPharma, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, as Rights Agent (the “Rights Agent”).
WITNESSETH:Purchase Agreement • May 12th, 1997 • Endorex Corp • Pharmaceutical preparations • New York
ARTICLE I VOTING AGREEMENTVoting Agreement • August 14th, 2001 • Endorex Corp • Pharmaceutical preparations • Delaware
EXHIBIT 10.29 CONSULTING AGREEMENT THIS AGREEMENT (this "Agreement") is entered into as of November 29, 2001 by and between Endorex Corporation, a Delaware Corporation located at 28101 Ballard Drive, Suite F, Lake Forest, IL 60045, (the "Company"),...Consulting Agreement • April 1st, 2002 • Dor Biopharma Inc • Pharmaceutical preparations • Illinois
FIRST AMENDMENTLicense Agreement • October 2nd, 2001 • Endorex Corp • Pharmaceutical preparations
WARRANT TO PURCHASE SHARES OF COMMON STOCK SOLIGENIX, INC.Security Agreement • July 9th, 2024 • Soligenix, Inc. • Pharmaceutical preparations
THIS WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, [__], or its assigns (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 10, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Soligenix, Inc., a Delaware corporation (the “Company”), up to [__] shares of Common Stock, par value $0.001 per share (the “Common Stock”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 31st, 2017 • Soligenix, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 31, 2017, between Soligenix, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Exhibit 10.28 FORM OF AFFILIATE AGREEMENT Endorex Corporation 28101 Ballard Drive, Suite F Lake Forest, Illinois 60045 Attention: Michael S. Rosen, Chief Executive Officer Ladies and Gentlemen: The undersigned is director or officer and/or a holder of...Affiliate Agreement • October 2nd, 2001 • Endorex Corp • Pharmaceutical preparations
PURCHASE AGREEMENTPurchase Agreement • March 24th, 2016 • Soligenix, Inc. • Pharmaceutical preparations • Illinois
PURCHASE AGREEMENT (the “Agreement”), dated as of March 22, 2016, by and between SOLIGENIX, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”).
WITNESSETH:Subscription Agreement • July 21st, 2003 • Dor Biopharma Inc • Pharmaceutical preparations • New York
EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • July 31st, 2015 • Soligenix, Inc. • Pharmaceutical preparations • New York
THIS EQUITY PURCHASE AGREEMENT entered into as of the [______] day of July, 2015 (this "AGREEMENT"), by and between [______], a [STATE] [TYPE OF ENTITY] ("INVESTOR"), and SOLIGENIX, INC., a Delaware Corporation (the "COMPANY").
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • June 24th, 2013 • Soligenix, Inc. • Pharmaceutical preparations • New York
The restrictions set forth herein shall not apply to: (a) if the undersigned is a natural person, any Transfers made by the undersigned (i) as a bona fide gift to any member of the immediate family (as defined below) of the undersigned or to a trust the beneficiaries of which are exclusively the undersigned or members of the undersigned’s immediate family, (ii) by will or intestate succession upon the death of the undersigned; or (iii) any Transfer to an affiliate (as defined below) of the undersigned if the Transfers do not involve a public distribution or public offering and provided the transferee agrees in writing as a condition precedent to such Transfer to be bound by the terms hereof, (b) if the undersigned is a corporation, partnership, limited liability company or other business entity, any Transfers to any shareholder, partner or member of, or owner of a similar equity interest in, the undersigned, as the case may be, if, in any such case, such Transfer is not for value; (c)
